January 31, 2018 Journal article Open Access

Hongming, Chen; Engkvist, Ola; Wang, Yinhai; Olivecrona, Marcus; Blaschke, Thomas

Citation Style Language JSON Export

{
  "DOI": "10.1016/j.drudis.2018.01.039", 
  "language": "eng", 
  "author": [
    {
      "family": "Hongming, Chen"
    }, 
    {
      "family": "Engkvist, Ola"
    }, 
    {
      "family": "Wang, Yinhai"
    }, 
    {
      "family": "Olivecrona, Marcus"
    }, 
    {
      "family": "Blaschke, Thomas"
    }
  ], 
  "issued": {
    "date-parts": [
      [
        2018, 
        1, 
        31
      ]
    ]
  }, 
  "abstract": "<p>Over the past decade, deep learning has achieved remarkable success in various artificial intelligence research areas. Evolved from the previous research on artificial neural networks, this technology has shown superior performance to other machine learning algorithms in areas such as image and voice recognition, natural language processing, among others. The first wave of applications of deep learning in pharmaceutical research has emerged in recent years, and its utility has gone beyond bioactivity predictions and has shown promise in addressing diverse problems in drug discovery. Examples will be discussed covering bioactivity prediction, <em>de novo</em> molecular design, synthesis prediction and biological image analysis.</p>", 
  "title": "The rise of deep learning in drug discovery", 
  "type": "article-journal", 
  "id": "1175821"
}